Showing for Sample Type: OOC
29 Samples visible to you, out of a total of 29
| ID | Title | UID | Name | Parent | Type | Stimulation | Scientist | Protocol | Protocol_Device | Material |
|---|---|---|---|---|---|---|---|---|---|---|
| ID | Title | UID | Name | Parent | Type | Stimulation | Scientist | Protocol | Protocol_Device | Material |
| 12309 | OOC-230201KAM-1 | OOC-230201KAM-1 | Fibrin Clots Control 0% | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Clot Formation | 0% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12310 | OOC-230201KAM-2 | OOC-230201KAM-2 | Fibrin Clots 5% | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Clot Formation | 5% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12311 | OOC-230201KAM-3 | OOC-230201KAM-3 | Fibrin Clots 25% | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Clot Formation | 25% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12312 | OOC-230201KAM-4 | OOC-230201KAM-4 | Fibrin Clots 50% | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Clot Formation | 50% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12313 | OOC-230201KAM-5 | OOC-230201KAM-5 | Beads Control | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Bead Perfusion | 0% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12314 | OOC-230201KAM-6 | OOC-230201KAM-6 | Beads 5% | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Bead Perfusion | 5% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12315 | OOC-230201KAM-7 | OOC-230201KAM-7 | Beads 25% | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Bead Perfusion | 25% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12316 | OOC-230201KAM-8 | OOC-230201KAM-8 | Beads 50% | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Bead Perfusion | 50% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12317 | OOC-230201KAM-10 | OOC-230201KAM-10 | Fibrin Clots 25% and Dextran | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Clot Formation | 25% Plasma; Dextran | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12318 | OOC-230201KAM-11 | OOC-230201KAM-11 | MDA-MB-231 Extravasation Control | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | Control | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12319 | OOC-230201KAM-12 | OOC-230201KAM-12 | MDA-MB-231 Extravasation Fibrinogen | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | Fibrinogen | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12320 | OOC-230201KAM-13 | OOC-230201KAM-13 | MDA-MB-231 Extravasation Thrombin | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | Thrombin | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12321 | OOC-230201KAM-14 | OOC-230201KAM-14 | MDA-MB-231 Extravasation Fibrinogen and anti-ICAM1 antibody | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | Fibrinogen; anti-ICAM1 antibody | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12322 | OOC-230201KAM-15 | OOC-230201KAM-15 | MDA-MB-231 Extravasation Thrombin and anti-PAR1 | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | Thrombin; PM2 | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12323 | OOC-230201KAM-16 | OOC-230201KAM-16 | SKBR3 Extravasation Control | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-4 | Cancer Cell Extravasation | Control | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12324 | OOC-230201KAM-17 | OOC-230201KAM-17 | SKBR3 Extravasation Fibrinogen | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-4 | Cancer Cell Extravasation | Fibrinogen | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12325 | OOC-230201KAM-18 | OOC-230201KAM-18 | MCF7 Extravasation Control | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-5 | Cancer Cell Extravasation | Control | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12326 | OOC-230201KAM-19 | OOC-230201KAM-19 | MCF7 Extravasation Thrombin | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-5 | Cancer Cell Extravasation | Thrombin | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12327 | OOC-230207KAM-1 | OOC-230207KAM-1 | MDA-MB-231 Extravasation Fibrin | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | 10% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12328 | OOC-230207KAM-2 | OOC-230207KAM-2 | Permeability Baseline | CEL-230131KAM-1; CEL-230131KAM-2 | Permeability | Control | Emmanuel Angelidakis | P.KAM-230131-V1_Confocal-imaging.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12329 | OOC-230207KAM-3 | OOC-230207KAM-3 | Permeability Thrombin | CEL-230131KAM-1; CEL-230131KAM-2 | Permeability | Thrombin | Emmanuel Angelidakis | P.KAM-230131-V1_Confocal-imaging.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12330 | OOC-230207KAM-5 | OOC-230207KAM-5 | Permeability 25% Plasma | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6 | Permeability | 25% Plasma | Emmanuel Angelidakis | P.KAM-230131-V1_Confocal-imaging.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12331 | OOC-230217KAM-1 | OOC-230217KAM-1 | Permeability Cold Control | CEL-230131KAM-1; CEL-230131KAM-2 | Permeability | Cold Control | Emmanuel Angelidakis | P.KAM-230131-V1_Confocal-imaging.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12332 | OOC-230217KAM-2 | OOC-230217KAM-2 | MDA-MB-231 Extravasation Fibrinogen and siRNA scramble control | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | Fibrinogen; scramble siRNA negative control | Sarah Shelton | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12333 | OOC-230217KAM-3 | OOC-230217KAM-3 | MDA-MB-231 Extravasation Fibrinogen and anti-ICAM1 siRNA1 | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | Fibrinogen; anti-ICAM1 siRNA1 | Sarah Shelton | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12334 | OOC-230217KAM-4 | OOC-230217KAM-4 | MDA-MB-231 Extravasation Fibrinogen and anti-ICAM1 siRNA2 | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-3 | Cancer Cell Extravasation | Fibrinogen; anti-ICAM1 siRNA2 | Sarah Shelton | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12335 | OOC-230217KAM-5 | OOC-230217KAM-5 | Platelet clots | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230217KAM-1 | Clot Formation | 10% Plasma with platelets | Emmanuel Angelidakis | P.KAM-230131-V1_clot-generate-and-image-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12336 | OOC-230217KAM-6 | OOC-230217KAM-6 | MCF7 Extravasation Thrombin and anti-PAR1 | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-5 | Cancer Cell Extravasation | Thrombin; PM2 | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
| 12337 | OOC-230217KAM-7 | OOC-230217KAM-7 | SKBR3 Extravasation Fibrinogen and anti-ICAM1 | CEL-230131KAM-1; CEL-230131KAM-2; CEL-230131KAM-6; CEL-230131KAM-4 | Cancer Cell Extravasation | Fibrinogen; anti-ICAM1 antibody | Emmanuel Angelidakis | P.KAM-230131-V1_cancer-cell-perfusion-and-extravasation-analysis.docx | P.KAM-230131-V1_OOC-protocol-device-and-network-creation.docx | Polydimethylsiloxane |
